Found: 7
Select item for more details and to access through your institution.
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium.
- Published in:
- 2022
- By:
- Publication type:
- journal article
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ASO Visual Abstract: Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer—A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 13, p. 8297, doi. 10.1245/s10434-021-10276-8
- By:
- Publication type:
- Article
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/8549487
- By:
- Publication type:
- Article
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 10, p. 1374, doi. 10.1093/bjs/znad210
- By:
- Publication type:
- Article